Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and drug candidates. Its structure supports blood-brain barrier penetration, making it valuable in central nervous system (CNS) drug design. The trifluoroacetamide group enhances metabolic stability and lipophilicity, improving pharmacokinetic properties. Commonly employed in medicinal chemistry for optimizing lead compounds in treatments targeting neurological disorders, inflammation, and certain cancers. Also utilized in agrochemicals for improving compound stability and efficacy.